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ABSTRACT 
The bacterium Mycoplasma gallisepticum is an avian respiratory pathogen that causes 
inflammation and swelling of conjunctiva in domestic poultry and wild finches. In the past, 
severity of conjunctivitis symptoms has been used to quantify infection severity and host 
resistance. However, many songbirds function as hosts to M. gallisepticum but do not 
develop this symptom at all. The absence of conjunctivitis, as well as other clinical signs, 
hinders our understanding of M. gallisepticum infection in the songbird community because 
some species are responding very differently than others. One such species is the Eastern 
Bluebird (Sialia sialis), a common songbird of the southeastern United States. In efforts to 
determine if M. gallisepticum is a respiratory pathogen of Eastern Bluebirds, data and 
samples collected from an experimental infection of wild-caught, captive housed birds were 
used. We quantified relative bacterial load in the eye conjunctiva and choanal cleft palate of 
infected birds and found that M. gallisepticum did not localize in the conjunctiva but was 
present in the palate of six out of nine birds 13 days following experimental infection. At this 
same time point, infected birds showed no significant difference in body condition measures 
when compared to controls but had significantly lower levels of circulating hemoglobin than 
did controls. Among infected birds, individuals with the greatest number of M. gallisepticum 
in their palate 13 days following infection lost more mass than did those with fewer bacteria. 
Hemoglobin levels and other measures of condition were not significantly correlated with 
pathogen load. These results suggest that although Eastern Bluebirds do not develop 
conjunctivitis, they are suffering from physiological consequences of infection. Furthermore, 
this could be the case in other host species that also do not develop conjunctivitis. 
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Introduction 
The study of emerging infectious diseases is key to broadening our understanding 
of the health of human populations and wildlife communities. A primary mode of disease 
diagnosis is via traditional clinical sign examination. For example, most humans with 
chickenpox are easily diagnosed simply by visual examination rather than having any sort 
of laboratory test run (Freer & Pistello 2018). This method of diagnosis can be 
problematic with many diseases as the type and severity of signs and symptoms may vary 
among individuals within a species as well as among different host species (Dhondt et al. 
2008, Dhondt et al. 2014). Furthermore, using clinical sign examination to diagnose 
disease is inadequate in the case of asymptomatic individuals as infected hosts lack 
clinical manifestations and may appear completely healthy (Laishram et al. 2012). While 
clinically asymptomatic individuals or species do not appear to be suffering from 
infection, they very well could be suffering from costly physiological consequences, 
similar to a symptomatic individual (Cheatsazan et al. 2013). Because of this, 
asymptomatic species can pass as unrecognized hosts.  
 Once an organism is infected by a pathogen, it can respond to the infection 
through passive tolerance or active immunological resistance to the pathogen (Råberg et 
al. 2008). There are costs associated with both ways of responding and host-pathogen 
relationships can vary greatly; thus, one method is not always superior. Mounting a 
strong immune response requires a significant amount of resources, and it is not always 
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beneficial to the host. When tolerating an infection, the host minimizes the damage done 
by the pathogen rather than trying to eliminate the pathogen. This can include repairing 
tissue damage done by the pathogen and up-regulating physiological mechanisms that 
normally maintain homeostasis to lessen the burden of being infected (Medzhitov et al. 
2012). If the negative effects of being infected by a pathogen are too great, a host may 
resist infection by employing its immune system to actively ward off the pathogen 
(Råberg et al. 2008). Often when a host is combating infection, the clinical signs and 
symptoms we associate with being sick, such as inflammation, fever, or mucus 
production, are results of a host’s immune response and not the pathogen itself (Chaplin 
2010). Therefore, a host that is displaying resistance to a pathogen, in many cases, will be 
obviously symptomatic.  
Mycoplasma is a genus of bacteria which includes species that are often obligate 
pathogens to animals or plants (Levisohn & Kleven 2000). Relationships between 
Mycoplasma species and their hosts have been of growing research interest as 
advancements have been made towards understanding Mycoplasma pathogenicity, or 
how they infect and persist within a host (Rottem 2003; Citti et al. 2010). Mycoplasma 
species are capable of antigen switching, meaning they can alter their surface proteins. 
This aids in avoiding detection by a host’s immune system and is a likely reason these 
species may continue to persist within hosts that mount a strong immune response (Razin 
et al. 1998; Levisohn & Kleven 2000; Citti et al. 2010).  
Pathogenic species within the genus Mycoplasma are commonly found in the 
mucosal membranes of the respiratory tract, urogenital tract, eyes, mammary glands, and 
joints of an infected host (Levisohn & Kleven 2000). Common symptoms of pathogenic 
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mycoplasmas, such as M. pneumoniae, include ocular manifestations such as 
conjunctivitis and uveitis, respiratory distress, and hemolytic anemia (Liu & Janigian 
2013; Waites & Talkington 2004). Other symptoms associated with Mycoplasma 
infections involve irregular weight patterns, such as reductions in weight gain and carcass 
value in cattle infected with M. bovis (Rosengarten & Citti 1999). 
Mycoplasma gallisepticum is an avian pathogen that causes chronic respiratory 
disease in chickens, and infectious sinusitis in turkeys (Kleven 2003). Mycoplasma 
gallisepticum can be transmitted vertically as well as horizontally (Kleven 2003; Nolan et 
al. 2004; Adelman et al. 2013).  Horizontal transmission can occur from direct contact 
with an infected bird, or indirectly such as through contaminated food or water (Kleven 
2003). Although a host can symptomatically recover from the disease, they often remain 
chronic carriers of M. gallisepticum and may continue to transmit it to others (Kleven 
2003). Controlling M. gallisepticum infection is therefore difficult for poultry farmers 
that house many birds in a small space (Kleven 2003; Osman et al. 2009). Thus, M. 
gallisepticum is able to spread rapidly, and its emergence typically leads to culling of 
entire flocks (Evans et al. 2005).  
Common symptoms seen in birds infected with M. gallisepticum include 
coughing, sneezing, nasal discharge, periorbital swelling, and conjunctivitis (Kleven 
2003). Such conjunctivitis is associated with eyes that are red and puffy and ocular 
discharge. In some cases, the eyes swell until they are completely closed, rendering the 
host effectively blind (Kleven 2003). Conjunctivitis can be defined as infection and 
inflammation of the conjunctiva (Azari & Barney 2013). The conjunctiva is a thin 
mucous membrane that lines the sclera of the eye as well as the inside of the eyelids 
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(Azari & Barney 2013). Conjunctivitis associated with M. gallisepticum infection is not 
caused directly by the bacteria. Instead, it is the host’s immune response to the pathogen 
that is resulting in swelling and redness of the tissue surrounding the eye. 
In 1994, House Finches were found to be infected with M. gallisepticum (Fischer 
et al. 1997). As with chickens, conjunctivitis was the primary diagnostic symptom of M. 
gallisepticum infection. In House Finches, conjunctivitis develops approximately four 
days after inoculation (Kollias et al. 2004). Furthermore, M. gallisepticum was found to 
be localized in the conjunctiva of infected House Finches (Fischer et al. 1997). In a study 
of House Finches experimentally inoculated with M. gallisepticum, Vinkler et al. (2018) 
found the severity of conjunctivitis was correlated with conjunctival pathogen load as 
well as pro-inflammatory interleukin 1 beta signaling. This suggests that the harm done to 
House Finches infected with M. gallisepticum is at least in part due to the birds’ pro-
inflammatory immune response (Vinkler et al. 2018). In previous studies conducted on 
House Finches experimentally infected with M. gallisepticum, disease progression has 
been monitored using several different methods, including scoring eye symptoms. Eye 
scoring involves ranking the intensity of conjunctivitis for each bird and serves as a 
measure of symptom severity (Kollias et al. 2004; Balenger et al. 2015), which correlates 
with finch tolerance, resistance, and rate of recovery from infection with M. gallisepticum 
(Kollias et al. 2004; Hill & Farmer 2005; Adelman et al. 2013). In recent years it has 
become common to also quantify M. gallisepticum load, or the relative number of M. 
gallisepticum cells harbored in the eye conjunctiva of infected finches in order to 
evaluate individual and population-level resistance (Bonneaud et al. 2011; Hawley et al. 
2012; Adelman et al. 2013). 
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Mycoplasma gallisepticum is now known to infect dozens of species of passerines 
(Dhondt et al. 2014; Farmer et al. 2005; Ley et al. 2016), including Eastern Bluebirds 
(Balenger, unpubl. data). Unlike House Finches, Eastern Bluebirds do not develop 
conjunctivitis in response to M. gallisepticum infection (Balenger, unpubl. data). Because 
Eastern Bluebirds do not develop conjunctivitis, they are not suffering from the negative 
effects associated with that swelling, such as impaired vision. Although Eastern 
Bluebirds do not develop conjunctivitis and appear asymptomatic, they do mount a strong 
humoral immune response when infected, developing antibodies to M. gallisepticum 
within 13 days of infection (Balenger, unpubl. data).  
 The first objective of this study was to determine if M. gallisepticum is causing a 
disease state in Eastern Bluebirds. We asked whether there were physiological costs 
associated with being experimentally infected with M. gallisepticum. We predicted that 
birds infected with M. gallisepticum would have lower mass and lower overall body 
condition compared to controls. If M. gallisepticum infection is causing hemolytic 
anemia, we also predicted that infection would result in relatively low levels of 
circulating hemoglobin. Furthermore, considering the absence of conjunctivitis, we aimed 
to determine where M. gallisepticum was localizing in infected birds. If it is present in the 
eye conjunctiva in the absence of conjunctivitis, this would be consistent with a tolerant 
phenotype in response to infection with M. gallisepticum. If M. gallisepticum is not 
present in the eye conjunctiva, but instead only found in the choanal cleft, this would 
suggest that the mucosal lining of the eyes of Eastern Bluebirds is a poor match or an 
undesirable environment for M. gallisepticum compared to that of species that do develop 
conjunctivitis. Finally, if infection is costly in some way, we asked if the relative amount 
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of M. gallisepticum in the conjunctiva or choanal cleft relates to those costs. If Eastern 
Bluebirds are rigorously resisting M. gallisepticum infection, we predicted that an 
increased pathogen load would be correlated with greater loss of mass and decreased 
body condition. If Eastern Bluebirds are tolerating the infection, we predicted that birds 
with greater pathogen loads would not lose mass or body condition relative to those with 
low pathogen loads. We also examined whether pathogen load affected circulating 
hemoglobin levels. Because hemolysis of red blood cells is a result of pathogenesis, not 
host immunity, we predicted that lower pathogen loads would correspond with relatively 
higher hemoglobin levels regardless of whether hosts are relatively resistant or tolerant 
(Messick 2004).
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Methods 
Sample sources 
In this study, measures of body condition, individual mass, mass change, and 
hemoglobin levels as well as choanal cleft palate swabs and conjunctival samples 
collected from a previously done experimental infection were used. For use in the 
experimental infection, wild male and female adult Eastern Bluebirds were captured at 
the University of Mississippi Field Station (Abbeville, MS, USA) from April-June 2017. 
At the time of capture, standard measures of body condition were collected (mass and 
wing length), as well as samples to test for the presence of active or prior M. 
gallisepticum infection. To do so, the choanal cleft palate of each bird was swabbed and a 
small blood sample from the brachial wing vein was collected. Choanal swabs were 
tested for M. gallisepticum DNA via polymerase chain reaction (PCR) using species-
specific primers for the cytadhesin gene mgc2 (Roberts et al. 2001), and blood serum was 
tested for M. gallisepticum antibodies using a serum plate agglutination assay (SPA; 
Charles River Laboratories). Only birds that were confirmed to have had no prior 
exposure to M. gallisepticum were used. Birds that were found to be previously exposed 
were released back into the local populations. Subsequently, 24 birds (12 male, 12 
female) were quarantined for inclusion in the experiment.  
All birds were quarantined to individual cages (40’ x 20’ x 20’) at the University 
of Mississippi for a period of at least 30 days. After the quarantine period, all birds were 
retested for M. gallisepticum antibodies and presence of M. gallisepticum DNA from 
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blood and swab samples; one bird tested positive for antibodies at this time and was 
removed from the study. Beginning on the day of capture, birds were fed 30 g of 
mealworms (Fluker Farms) per day. This amount was roughly equivalent to adult body 
mass (capture mass range: 25.7-30.8 g) and has been found previously to provide ad 
libitum intake to Eastern Bluebirds (Siefferman, pers. comm.). Following the premature 
death of two infected birds that had suffered high mass loss (Balenger, unpubl. data), 
however, 60 g of mealworms were provided to the surviving infected birds for the last 
four days of the experiment (Figure 1). By this date, control birds had already been 
euthanized (see below), thus, the amount of food was only adjusted for birds infected 
with M. gallisepticum and not for the individuals inoculated with sterile media. 
Throughout the experiment, birds were also provided with water that included a soluble 
vitamin supplement (Wild Harvest Premium Multi-Drop for birds).  
Figure 1. Timeline showing the critical timepoints and dates on which measurements and samples 
were taken for a) control and b) M. gallisepticum infected birds. (D: day) 
 
The day before inoculation, mass and hemoglobin levels of each bird were 
measured (Figure 1). To measure hemoglobin, a sterile needle was used to puncture the 
Inoculation 
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brachial wing vein, and a small drop of blood was collected directly into a capillary 
cuvette. Hemoglobin level (g/dL) was then determined using a HemoCue Hb 201+. 
The following day, birds were inoculated with SP4 sterile culture media or a 
cultured M. gallisepticum field isolate collected from a House Finch in January 2007 
following standard protocols (Farmer et al. 2005; Bonneaud et al. 2011; Balenger et al. 
2015). Briefly, birds were infected with 20 µL of 1 × 104 to 1 × 106 color changing units 
of culture via ocular inoculation. Control and infected birds were maintained within the 
same room, separated by ZipWalls to limit any aerosolized spread of the pathogen. For 
the next 14 days, birds were monitored daily for signs of conjunctivitis. 
Thirteen days following inoculation, mass and hemoglobin measures were 
collected again, as well as choanal swabs (Figure 1). Briefly, sterile culture swabs were 
inserted into the beak of each bird and gently swirled against the choanal cleft palate for 3 
seconds. Swabs were placed at -20°C until DNA extraction was performed. The 
following day, birds were anesthetized with isoflourane and euthanized via rapid 
decapitation. At this time, the right eyes along with the surrounding conjunctival 
membrane were removed from the skull and stored in RNAlater at -80°C. All animal 
protocols and procedures were approved by the Institutional Care and Use Committee of 
the University of Mississippi (protocol #17-012) as well as state (0119183) and federal 
(MB13567C-1) collecting permits granted to S. L. Balenger. 
DNA extraction 
Conjunctiva and eye samples were placed in phosphate buffer solution (PBS) at 
4°C for 24 hours prior to extraction to allow tissues to rehydrate. Using sterile forceps 
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and a sterile razor blade to mince the eye into small pieces, we homogenized the 
previously collected eye tissue. The tissue was placed into a sterile 5 mL tube with 360 
µL of Qiagen ATL buffer and 200 µL of Qiagen proteinase K. A sterile pestle was used 
to grind the contents of the tube for 2-3 minutes. The mixture was then vortexed for 
approximately 10 seconds. This procedure of grinding and vortexing was repeated as 
necessary until the mixture resembled a “slurry”. The mixture was then transferred to a 
1.5 mL tube and ground further with a new sterile pestle and periodic vortexing for 5 
second intervals. The samples were then placed at 56°C for 48 hours. A 40 µL aliquot of 
the homogenized tissue was extracted using a Qiagen DNeasy Blood and Tissue Kit and 
following the standard kit protocol. 
Choanal swabs were extracted similar to Staley et al. (2018). Briefly, each swab 
was thawed and transferred to microcentrifuge tubes containing 200 µL of sterile water. 
Samples were incubated at 95°C for 10 minutes to burst cells, releasing their contents 
from the swabs into solution. Samples were placed on ice for 10 minutes and the swabs 
were removed from the tubes. DNA was extracted from samples using a Qiagen DNeasy 
Blood and Tissue Kit and following the standard kit protocol.  
Quantitative PCR  
We used quantitative PCR (qPCR) to determine the bacterial load of both the 
right eye samples and swabs from the choanal cleft palate. The DNA concentration of all 
samples was measured using BioTek’s Epoch Microplate Spectrophotometer and Gen5 
data analysis software. Conjunctival samples were diluted to 10 ng/µL. Because the DNA 
yields from some choanal swab extractions were too low to normalize, conjunctival DNA 
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concentrations ranged from 1-10 ng/µL. The results of our standard curve confirmed that 
these concentrations were sufficient for detection of low levels of M. gallisepticum 
(Figure 2). Reactions followed the TaqMan-based assay as described in Grodio et al. 
(2008).  The genes that were amplified during the reaction were a single-copy Eastern 
Bluebird gene, rag-1, and a single-copy M. gallisepticum gene, mgc2. The use of the rag-
1 gene served as an internal control for the reaction as it 1) confirmed the presence of 
Bluebird DNA regardless of whether the samples amplified for the mgc2 gene, and 2) 
could be used to normalize the relative amount of M. gallisepticum DNA in choanal 
swabs. Controls included water, M. gallisepticum DNA extracted from cells grown in 
culture, and Eastern Bluebird DNA from an individual negative for M. gallisepticum. 
Using Qiagen’s QIAgility system, 15 µL of the pre-made master mixes were pipetted into 
each of the wells of a single Rotor-Gene Q 72-well rotor disc. Half of the wells contained 
the rag-1 gene master mix and the other half contained the mgc2 master mix. The 
QIAgility pipetted 5 µL of control or sample into the appropriate wells. All reactions 
were run on a single ring to avoid sample ring variation. Controls and samples were run 
in triplicate for each of the two primer pairs, a forward and reverse primer for rag-1 and 
mgc2 (Grodio et al. 2008).  The reaction was run on Qiagen’s Rotor-Gene Q real-time 
PCR system. The reaction parameters were as follows: 95°C for 20 seconds followed by 
45 cycles of 95°C for 3 seconds and 60°C for 30 seconds. 
Standard Curve 
To validate the qPCR assay, we made a standard curve using four tenfold serial 
dilutions of DNA from M. gallisepticum grown in cell culture media as well as Eastern 
Bluebird DNA. Starting with an original sample concentration of 10 ng/µL, 10 µL of 
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sample was added to 90 µL of water. This was repeated until reaching a final sample 
concentration of 0.001 ng/µL. Water was used as a no template control (NTC) in both 
reactions. Each of the Bluebird and M. gallisepticum DNA dilutions as well as the NTC 
was run in triplicate with each primer pair.  
Analysis 
Cycle quantification values (Cq) were determined using LinRegPCR. Cq values 
>40 were considered negative. Absolute quantity of M. gallisepticum in the eye plus 
conjunctiva tissue was calculated by interpolating Cq values into the standard curves. 
Because we did not obtain enough DNA from choanal swabs to standardize their reaction 
DNA concentrations, we could not use the standard curve to calculate the absolute 
number of M. gallisepticum present in this tissue. Instead, we calculated the relative 
amount of M. gallisepticum in each sample by comparing the mean rag-1 and mgc2 Cq 
values of each sample’s set of triplicates using the equation x̄ rag-1Cq/ x̄ mgc2Cq. These 
values were used to compare the relative quantity of M. gallisepticum to individual mass, 
mass change, body condition, and hemoglobin levels. Mass change was calculated as the 
difference in mass between the day before the experiment and 13 days following 
infection. Body condition was calculated as mass 13 days following inoculation relative 
to wing length on the day of capture. This minimizes the effects of captivity on wing 
wear. 
We used Kruskal-Wallis tests to statistically determine if measurements of 
individual mass, mass change, body condition, and hemoglobin levels of infected birds 
were significantly different than those of control birds. Spearman rank order correlations 
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of individuals inoculated with M. gallisepticum were calculated with respect to individual 
mass, mass change, body condition, and hemoglobin levels to determine if any of these 
measurements was significantly correlated with pathogen load. 
  
14 
 
Results 
Of the 11 birds infected with M. gallisepticum in this experiment, two died before 
the experiment was completed. Before dying, one of the birds lost 33% of mass by day 8 
and the other lost 30% of mass by day 9. Thus, the final sample sizes for control and 
infected groups were 12 and 9, respectively. 
The qPCR-based rag-1 and mgc2 standard curves are shown in Figure 2. These 
curves were ultimately not used to quantify the amount of M. gallisepticum in the 
conjunctiva because the mgc2 locus did not amplify from any of the DNA extracted from 
tissue associated with the eye. However, of the nine experimentally infected birds, six 
tested positive for M. gallisepticum in the choanal cleft palate 13 days following 
inoculation. 
Figure 2. Standard curves of a) rag-1 and b) mgc2. Line equations and regression coefficients are 
provided for each dilution series. 
a)      b) 
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Mass, mass change, and body condition did not significantly differ 13 days 
following inoculation between infected and uninfected birds. However, birds that were 
infected were found to have lower levels of circulating hemoglobin than control birds 
(Table 1, Figure 3). When examining only those birds infected with M. gallisepticum, we 
found that birds with a greater pathogen load 13 days following inoculation lost the most 
mass over the course of the infection (Table 2). No other measures of condition or 
pathology were significantly associated with M. gallisepticum load (Table 2). 
Table 1. Results of Kruskal-Wallis tests assessing whether inoculation with M. gallisepticum 
affects condition or health compared to control birds that remained uninfected throughout the 
experiment. Significant p-values are in bold.  
 degrees of 
freedom 
χ2 p-value 
Body condition 1 2.020 0.155 
Mass change (g) 1 1.293 0.256 
Hemoglobin (g/dL) 1 3.824 0.050 
Mass (g) 1 3.416 0.065 
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Figure 3. Mean a) body condition, b) mass change, c) hemoglobin level, and d) individual mass of 
birds inoculated with M. gallisepticum and control birds with standard error bars. An asterisk 
identifies a significant difference observed between the control and M. gallisepticum inoculated 
groups.  
 
 
Table 2. Spearman rank order correlations of individuals inoculated with M. gallisepticum. Each 
column shows the effect size (rho), associated p-value, and sample size (n). Significant p-values 
are in bold. 
 
 
Body condition 
Mass 
change (g) 
Hemoglobin 
(g/dL) Mass (g) 
Pathogen 
load 
 
rho 
 
-0.034 -0.712 -0.475 -0.223 
 
 
p-value 0.931 0.031 0.1967 0.552 
 
 
n 9 9 9 9 
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Discussion 
Previous studies investigating the cost of M. gallisepticum infection upon 
songbird hosts have primarily relied on the presence of visual scoring of conjunctivitis 
symptoms to evaluate the severity of disease state, host resistance, and pathogen 
virulence (Farmer et al. 2005; Balenger et al. 2015). Here we showed that relying solely 
on this metric is inadequate for Eastern Bluebirds, which suffer from costly pathogenesis 
when infected with M. gallisepticum but never develop symptoms of conjunctivitis. 
Unlike in House Finches, M. gallisepticum does not localize to the eye conjunctiva of 
Eastern Bluebirds following infection; this is likely the factor behind the lack of ocular 
swelling in response to infection. We did find, however, that M. gallisepticum continues 
to persist within the choanal cleft palate for at least 13 days in infected Eastern Bluebirds, 
thus, this species is capable of functioning as a natural host in the wild. Infection per se 
was a predictor of hemoglobin levels, such that infected birds had lower levels of 
circulating hemoglobin. Using relative pathogen load data among experimentally infected 
birds, we were able to investigate whether the amount of pathogen remaining 13 days 
after inoculation, a metric of resistance, was related to costs of pathogenesis or immunity. 
We found that relative pathogen load was a determinant of the amount of mass lost over 
the course of the experiment. Essentially, those birds with the highest pathogen load had 
also lost the most mass. Evidence from similar studies of M. gallisepticum infected 
House Finches supports the interpretation that birds’ observed mass loss is not occurring 
  
18 
 
as cost to the host for mounting an immune response, but instead these birds are suffering 
the most from pathogenesis (Bonneaud et al. 2012). 
To investigate the cost of infection, as opposed to the cost of immunity, on 
Eastern Bluebird health, we examined host levels of circulating hemoglobin. We found 
that experimentally infected Eastern Bluebirds had significantly lower hemoglobin levels, 
suggesting that M. gallisepticum causes anemia in this host species. Many members of 
the Mycoplasma genus are hemotropic; adhering to, colonizing, and growing upon host 
erythrocytes (Messick 2004). Commonly referred to as haemoplasmas, hemotropic 
mycoplasmas are red blood cell pathogens that generate host infectious anemia (Messick 
2004). Messick et al. (2002) identified the pneunomiae clade of Mycoplasma (which 
includes M. gallisepticum) as being closely related to the monophyletic group of 
haemoplasmas. In fact, although it is relatively rare, M. pneumoniae is known to cause 
hemolytic anemia in humans (Waites & Talkington 2004). Confirming that M. 
gallisepticum is the underlying cause of anemia in infected Eastern Bluebirds should 
therefore be pursued in future studies. 
Somewhat surprisingly, we found that experimentally infected Eastern Bluebirds 
did not have M. gallisepticum present in their eye conjunctiva on day 14. DNA collected 
from the choanal cleft palate, however, identified the presence of M. gallisepticum in the 
palate of six of the nine surviving infected birds 13 days after the initial ocular 
inoculation.  
Grodio et al. (2008) proposed that, at least for House Finches, bacterial load 
correlates with development and severity of conjunctivitis. In the current study, the 
absence of M. gallisepticum in the eye conjunctiva of ocularly infected birds is a likely 
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explanation for why Eastern Bluebirds do not develop conjunctivitis. It is possible that 
the conditions encountered by M. gallisepticum in the conjunctival lining surrounding the 
eyes in Eastern Bluebirds differ from that of House finches in ways that make it 
inhospitable to M. gallisepticum. 
During this experiment, two infected birds died due to rapid and dramatic mass 
loss (Balenger, unpubl. data), one on day 8 and one on day 9. In response to this 
mortality, the amount of food the birds were receiving was doubled to prevent any further 
deaths. House Finches rarely, if ever, die in captivity in response to infection with M. 
gallisepticum (Bonneaud et al. 2011), and the birds used in the current study had all 
increased in mass between capture in the wild and the start of the experiment on the same 
diet they were receiving when mortality occurred (Balenger, unpubl. data). Even after 
doubling the mass of food available to experimental birds 10 days post-infection, we 
found that variation in mass change among infected birds still was related to M. 
gallisepticum load. Eastern Bluebirds harboring the most M. gallisepticum 13 days after 
inoculation lost the most mass over the course of the infection. The change to food being 
administered ad libitum on day 10 is likely to have affected the results of our 
investigation of the physiological costs associated with M. gallisepticum infection. 
Control birds did not receive the increased amount of food because they had already been 
euthanized at this time. It is possible that if all birds had remained this feeding schedule 
for the entirety of the study then infected birds would have increased their caloric uptake 
and therefore have more resources to put towards responding immunologically. It would 
be valuable to explore dietary manipulations in the future to determine how calories 
available interact with immunity. Infection with M. gallisepticum clearly increases 
  
20 
 
energetic costs to Eastern Bluebirds and survival rates and optimal physiological 
strategies of infected hosts will likely vary depending on availability of resources. 
According to a long-term database (ebird.com) compiled by the Cornell Lab of 
Ornithology, Eastern Bluebird abundance during breeding and non-breeding seasons have 
been declining over large portions of their range between 2007-2016 (Figure 4). It is 
possible that M. gallisepticum infection could be related to the documented decreases in 
abundance. Because Eastern Bluebirds are still commonly found, these decreases in 
abundance can go unnoticed by the general population. It is important to take these data 
into consideration and investigate the possibility of M. gallisepticum infection being a 
factor in population size reductions. The same notion can apply for other novel M. 
gallisepticum host species experiencing similar decreases in abundance.  
Figure 4. Map of changes in relative abundance of Eastern Bluebirds from years 2007-2016 
during a) breeding season months (May 31 - Jul 6)  and b) non-breeding season months (Nov 30 - 
Dec 28). Image provided by eBird (www.ebird.org) and created [November 2018]. 
 
a) b) 
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Although, at the surface, Eastern Bluebirds seem to be asymptomatic hosts of M. 
gallisepticum, this study showed that they do suffer from physiological costs when 
infected. We hypothesize that this could be the case with other avian species that are 
currently viewed as carriers or reservoirs of M. gallisepticum. In the past, non-
conjunctivitis-developing host species of M. gallisepticum were thought to suffer little to 
no cost of infection. For Eastern Bluebirds, this is clearly untrue. It is possible that there 
are other host species harboring the pathogen that do not develop conjunctivitis but also 
suffer from negative health consequences. Going forward, research should aim to 
determine if M. gallisepticum is having significant negative effects on the health of hosts. 
These relationships can give insight into how different host species are responding to 
infection in terms of coping strategies such as tolerance and resistance and whether M. 
gallisepticum is influencing population and community dynamics in ways previously 
unrecognized.  
  This study contributes to the growing knowledge of M. gallisepticum infection in 
Eastern Bluebirds. Our results show that Eastern Bluebirds are experiencing negative 
health effects after infection. Although these birds do not suffer from the consequences of 
conjunctival inflammation, they are likely facing physiological costs of infection.
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